VENLOR
Herpes Zoster
Beijing Tiantan HospitalSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 89/ 100
Competitive context
5 Active assets in the Herpes Zoster cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Capsaicin NeurogesX | Phase 3 | BBB |
ZOSTER VACCINE, LIVE, (OKA/MERCK) Louis Stokes VA Medical Center | Phase 4 | BBB |
Pregabalin CMH Kharian Medical College | Phase 4 | BB |
Foscarnet Cttq | Phase 4 | BB |
Gabapentine Dominik Irnich | Phase 4 | BB |
View all 25 →
Same molecule, other indications
VENLOR is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →